Alamar Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALMR Nasdaq 2836 alamarbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alamar Biosciences, Inc.

Kardigan And 2 Founder Run Stocks To Own - Oct 20th, 2026 9:15 am
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026 - Oct 8th, 2026 2:05 pm
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - Oct 5th, 2026 2:05 pm
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment - Sep 24th, 2026 4:51 pm
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - Sep 1st, 2026 2:05 pm
Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript - Aug 17th, 2026 6:14 pm
Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call Highlights: Revenue Surges 82% on 147% ... - Aug 10th, 2026 11:02 pm
Alamar Biosciences (ALMR) Stock Trades At A Premium To Its Sales - Aug 10th, 2026 7:08 pm
Alamar Biosciences Q2 Earnings Call Highlights - Aug 10th, 2026 4:04 pm
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance - Aug 10th, 2026 2:05 pm
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures - Aug 10th, 2026 2:03 pm
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq - Aug 6th, 2026 4:46 am
Attovia adds to biotech IPO momentum with $289M offering - Aug 5th, 2026 6:05 am
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome - Jul 28th, 2026 2:12 pm
ALZpath Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease - Jul 23rd, 2026 6:30 am
Braveheart, Attovia join next wave of biotech IPOs - Jul 15th, 2026 5:34 am
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 - Jul 14th, 2026 2:05 pm